Table 2

Vaccine trial counts by cancer types and trial phase.

Cancer Type

Phase 1

Phase 2

Phase 3

Phase 4

Unspecified

Total


Melanoma

43

107

9

7

166

Cervix

6

23

35

1

5

70

Breast

37

27

1

4

69

Prostate

20

37

4

3

64

Lung

25

28

5

2

60

Ovary

24

11

1

3

39

Non-Hodgkin lymphoma

7

20

7

1

2

37

Colon

11

22

3

36

Kidney

7

23

2

32

Rectum

9

18

3

30

Pancreas

8

17

3

1

29

CML

9

14

1

24

AML

9

10

1

3

23

Myeloma

5

12

2

2

21

Brain

11

8

1

20

Eye

4

14

2

20

Other oral cavity

10

5

15

Pharynx

10

4

1

15

Mouth

10

4

14

All sites

10

3

1

14

Liver

5

7

2

14

CLL

8

5

13

Soft tissue

7

5

1

13

Stomach

8

3

11

Esophagus

6

2

8

Hodgkin lymphoma

2

5

1

8

ALL

3

2

2

7

Bladder

5

1

1

7

Bone

3

2

1

6

Vulva

1

4

5

Testis

3

1

4

Vagina

4

4

Cranial nerves & other nervous system

1

1

1

3

Gallbladder & other billiary

2

1

3

Small intestine

1

1

1

3

Anus

1

1

Corpus

1

1

Other non-epithelial skin

1

0

1

Penis

1

1

Tongue

1

1

Total

189

348

72

2

34

645


The number of vaccine trials per cancer type and trial phase are illustrated. The columns are sorted by total trial number per cancer.

Cao et al. Immunome Research 2008 4:7   doi:10.1186/1745-7580-4-7

Open Data